|
|
||||||||
ORIGINAL RESEARCH |
From the Department of Environmental Health, Program for Population Genetics, Department of Maternal and Child Health, and Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts; Department of Environmental Health and Channing Laboratory, Department of Medicine, Brigham and Womens Hospital, Harvard Medical School, Boston, Massachusetts; Vitamin Bioavailability Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Boston, Massachusetts; New England Research Institutes, Watertown, Massachusetts; Beijing Medical University Center for Ecogenetics and Reproductive Health, Beijing, China; and Anhui Medical University, Anqing Biomedical Institute, Anhui, China.
Address reprint requests to: Alayne G. Ronnenberg, ScD, Harvard School of Public Health, Department of Environmental Health, FXB101, 665 Huntington Avenue, Boston, MA 02115; E-mail: ronnenberg{at}attbi.com.
| ABSTRACT |
|---|
|
|
|---|
METHODS: All women were aged 2134 years, had never smoked, and were primigravid. Patients (n = 49) were women with a clinically recognized pregnancy who experienced a fetal death before 100 days gestation. Controls (n = 409) were women who maintained a pregnancy that ended in a live birth. Homocysteine, folate, and vitamins B6 and B12 concentrations were measured in plasma obtained before conception.
RESULTS: Mean vitamin B6 concentration was lower in patients than in controls (34.0 versus 37.9 nmol/L, P = .04). In addition, the risk of spontaneous abortion tended to increase with decreasing plasma vitamin B6 and folate concentration (P for trend = .06 and .07, respectively), although the significance of these trends was further reduced in logistic models that included age, body mass index, and both vitamins. The risk of spontaneous abortion was four-fold higher among women with suboptimal plasma concentrations of both folate and vitamin B6 (folate less than or equal to 8.4 nmol/L and vitamin B6 less than or equal to 49 nmol/L) than in those with higher plasma concentrations of both vitamins (odds ratio 4.1, 95% confidence interval 1.2, 14.4). Homocysteine and vitamin B12 status were not associated with spontaneous abortion risk.
CONCLUSION: Suboptimal preconception folate and vitamin B6 status, especially when they occur together, may increase the risk of clinical spontaneous abortion. Additional prospective studies are needed to confirm these findings and to determine whether antenatal B vitamin supplementation reduces spontaneous abortion risk.
Spontaneous abortion is the most common adverse pregnancy outcome,1 affecting between 12% and 15% of clinically recognized pregnancies.2 Although as many as half of clinical spontaneous abortions may be caused by chromosomal abnormalities, maternal factors, including nutritional status, also contribute to their occurrence. Poor folate status during pregnancy has been associated with a number of adverse pregnancy outcomes, including spontaneous abortion,3,4 placental abruption,5 pre-term delivery, and infant low birth weight.6 Although less information is available on the pregnancy risks associated with poor vitamin B6 status, lower plasma levels of pyridoxal-5'-phosphate, the active form of vitamin B6, have been observed in women with recurrent early pregnancy losses7 and those experiencing placental abruption or infarction8 compared with women with normal pregnancy outcomes. Elevated plasma concentrations of total homocysteine, caused by either genetic abnormalities or suboptimal folate, vitamin B12, and/or vitamin B6 status, also have been associated with increased risk of recurrent spontaneous abortion4,79 and other adverse pregnancy events.10,11
Despite evidence from observational studies that maternal B vitamin and homocysteine status influence the risk of spontaneous abortion,12 no studies to date have prospectively examined these relationships. The nutritional status of women who are attempting to become pregnant is likely to provide a better picture of the early gestational environment than are measures taken during pregnancy because it is unaffected by the pregnancy-induced expansion of plasma volume, which dilutes most biochemical analytes.13 Assessment of homocysteine and B vitamin status just before pregnancy would also help to clarify the temporal relationship between early pregnancy complications, such as spontaneous abortion, and maternal nutritional status.
We recently reported a high prevalence of folate and vitamin B6 deficiencies in a group of Chinese women who were attempting to become pregnant.14 Because we also found that prenatal vitamin supplementation was uncommon in this area of China, we suspected that the high prevalence of vitamin deficiencies, coupled with the additional nutrient demands of pregnancy, could increase the risk of spontaneous abortion in these women. The purpose of this case-control study was to assess the association between prepregnancy B vitamin status and homocysteine concentrations and the risk of clinical spontaneous abortion in young Chinese women.
| MATERIALS AND METHODS |
|---|
|
|
|---|
At enrollment, height and body weight in light clothing were measured to the nearest 0.1 cm and 0.1 kg, respectively, with a beam weighing scale and measuring system. At that time, interviewers administered a previously validated questionnaire to the women and their husbands to collect baseline information on sociodemographic, environmental, and personal attributes that might be related to reproductive outcomes. Included among these variables were education level, type of shift worked (rotating or nonrotating), exposure to passive smoking at home, use of vitamin and/or mineral supplements, use of tea, and alcohol intake.
Nonfasting blood samples were obtained from women before the initial interview via venipuncture and were collected into 10-mL, metal-free, ethylenediaminetetraacetic acid-treated tubes. Blood was centrifuged, and plasma was obtained and stored at -20C until shipped on dry ice to the Harvard School of Public Health, where it was stored at -70C before nutritional analyses. Frozen samples were transported to the United States Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, MA, where plasma concentrations of homocysteine, folate, and vitamins B6 and B12 were measured. The Human Subjects Committees at the Harvard School of Public Health and Beijing Medical University approved all study procedures, and informed consent was obtained from each participant.
Total homocysteine concentration in plasma was determined using a method based on the principles described by Araki and Sako.15 Although analyses were performed on plasma samples obtained from nonfasting subjects at a single point in time, fasting status has been shown to have no appreciable effect on homocysteine concentrations,16 and nonfasting vitamin concentrations are frequently used to assess vitamin status.17,18 Plasma folate and vitamin B12 were determined by a radioimmunoassay method using a commercially available kit from BioRad Diagnostics Group (Hercules, CA). Plasma vitamin B6 (as pyridoxal-5'-phosphate) was measured by the tyrosine decarboxylase apoenzyme method.19 Homocysteine and vitamin measurements were completed in four batches over an 11-month period, with between 63 and 282 samples in each batch. Typical coefficients of variation for in-house control plasma samples were less than 8% for homocysteine, folate, and vitamin B12, and less than 6% for vitamin B6.
Statistical analyses were performed using SAS for Windows 8.0 (Cary, NC). Because of their skewed distributions, nutrition variables and covariates are presented as medians with the range or as geometric means with their 95% confidence intervals (CI). Differences between patients and controls were assessed using the Wilcoxon rank sum test (medians) or a t test on logarithmically transformed variables. Plasma vitamin concentrations were compared with published reference values to determine the proportion of patients and controls with biochemical evidence of vitamin deficiencies. Vitamin deficiency was defined as plasma concentrations less than 6.8 nmol/L (3 ng/mL) for folate,20 less than 30 nmol/L of pyridoxal-5'-phosphate for vitamin B6,21 and less than 221 pmol/L (300 pg/mL) for vitamin 22 B12. There is no standard definition of elevated homocysteine. We defined it for these analyses as a value greater than or equal to 15.5 µmol/L, which was greater than or equal to the 95th percentile for the combined cohort of patients and controls.
Differences in the proportions of spontaneous abortion patients and controls with vitamin deficiencies or elevated homocysteine were evaluated using
2 analyses and Fisher exact test (homocysteine). The association of spontaneous abortion with vitamin deficiencies or elevated homocysteine was estimated using logistic regression. Although the batch in which plasma samples were analyzed was not significantly associated with spontaneous abortion, we included categoric variables for the analytic batch in logistic models to control for variability among batches. To explore the relation between vitamin status and the risk of spontaneous abortion further, subjects were divided into quintiles according to their concentrations of folate and vitamin B6, and the relative odds of spontaneous abortion were assessed using logistic regression, with the highest vitamin quintile serving as the reference category. Dose-response relations for folate and vitamin B6 were assessed using the Mantel-Haenszel
2 test for trend.23 Potential confounding by age and body mass index (BMI) (as continuous variables) and the other vitamin (dichotomized) was controlled for using multiple logistic regression. We assessed the presence of effect modification by evaluating the significance of interaction terms created between nutrition variables (low folate, low vitamin B6) and covariates (age and BMI). Statistical significance refers to P
.05.
| RESULTS |
|---|
|
|
|---|
|
|
|
|
To examine the effects of suboptimal folate and vitamin B6 status combined, we defined a "nutritionally at-risk" group of 162 women (24 patients and 137 controls) who were below both the 40th percentile for folate (less than or equal to 8.4 pmol/L) and the 80th percentile (less than or equal to 49 nmol/L) for vitamin B6 and compared their risk of spontaneous abortion to that of 71 women (three patients and 68 controls) with plasma concentrations of both vitamins above these percentile cutoffs. After adjustment for age, BMI, and analytic batch, the risk of spontaneous abortion was four-fold higher (adjusted OR 4.1, 95% CI 1.2, 14.4, P = .03) among women with low plasma concentrations of both vitamins compared with those with higher concentrations of both vitamins.
| DISCUSSION |
|---|
|
|
|---|
To our knowledge, ours is the first prospective study to report an association between vitamin B6 status and spontaneous abortion. Wouters et al7 found elevated homocysteine and lower plasma concentrations of vitamin B6 (46 versus 51 nmol/L, P < .05) in women with histories of recurrent early fetal loss compared with control women, and Goddijn-Wessel et al8 reported similar findings of lower plasma vitamin B6 (42 versus 53 nmol/L, P < .05) among women with placental abruption or infarction. Because vitamin B6-dependent coenzymes participate in over 100 reactions involved in the metabolism of amino acids, lipids, nucleic acids, and glycogen24 as well as in the synthesis of neurotransmitters and heme,21 it seems plausible that maternal vitamin B6 status could influence early gestational events, including those related to spontaneous abortion. However, a precise mechanism for these possible effects has not been described.
In the current study, folate deficiency (plasma folate less than 6.8 nmol/L) tended to be more common among women with spontaneous abortion than in those with live births. The adjusted OR for spontaneous abortion (OR 1.7, 95% CI 0.9, 3.1, P = .09) associated with folate concentrations below 8.4 nmol/L (our 40th percentile) observed in this study is remarkably similar to the OR for recurrent spontaneous abortion (OR 1.9, 95% CI 0.8, 4.6) associated with the same serum folate concentration (their 10th percentile) recently reported by Nelen et al,4 although the association was not statistically significant in either study. These observations suggest that suboptimal folate status may play a role in both first and recurrent spontaneous abortion, but larger prospective studies are needed to confirm these possible associations.
We found that the risk of spontaneous abortion was particularly high (adjusted OR 4.1, 95% CI 1.2, 14.4) among women with suboptimal plasma concentrations of both folate (less than 40th percentile) and vitamin B6 (less than 80th percentile) compared with those in the upper ends of both vitamin distributions, which suggests that the detrimental effects of poor vitamin status may be additive. Additional nutritional status measures are needed to determine whether the increased risk of spontaneous abortion is related to these specific nutrients or to generally poor nutritional status before pregnancy. Assessment of dietary intake as well as more thorough documentation of the prepregnancy nutritional status of Chinese women would help to clarify these issues.
In contrast to the reports of others,4,7,9 we did not find a significant association between elevated homocysteine and spontaneous abortion risk. We did observe a non-significant doubling of the risk of spontaneous abortion among women with plasma homocysteine greater than or equal to 15.5 µmol/L (OR 2.0, 95% CI 0.6, 6.7), although this association appeared to be related to both age and BMI because adjustment for these variables further reduced the OR (data not shown). Our failure to detect a significant effect of elevated homocysteine might be due to the relatively small number of spontaneous abortion patients (n = 49), but it also may be related to the fact that our patients were experiencing their first occurrence of spontaneous abortion. Unlike the previous studies, which focused on women with recurrent pregnancy losses, women who reported a previous clinically recognized spontaneous abortion were excluded from the current study. Most women who experience a spontaneous abortion are able to conceive again and carry a pregnancy successfully to term. This observation suggests that nutritional and other factors that influence the risk of a first spontaneous abortion may be distinct from those associated with recurrent pregnancy loss.
A major strength of the current study is the ability to relate preconception B vitamin status, assessed in women planning to become pregnant, to events that occur in the subsequent pregnancy.25 Limitations of the study include the lack of information on chromosomal studies of the abortus, the small number of patients, and the lack of dietary data. Without detailed information on nutrient intake, we cannot determine whether the observed associations between spontaneous abortion and B vitamin status are due to insufficient dietary intake of these or other nutrients or whether the association is related to nondietary factors, such as altered nutrient absorption or metabolism or genetic polymorphisms that have been linked to recurrent pregnancy losses26 and other adverse pregnancy events.27,28
In summary, we found modest associations between the first occurrence of clinical spontaneous abortion and suboptimal folate and vitamin B6 status in young Chinese women. Plasma homocysteine and vitamin B12 concentrations were not related to spontaneous abortion. Additional pregnancy outcome studies among Chinese women of childbearing age are needed to document dietary intake and to determine the prevalence of genetic polymorphisms that may have both nutritional and reproductive implications. It also will be important to determine whether our observations apply to other populations. If they prove consistent, recent efforts to increase periconceptional folate intakes in China29 and the United States30 might reduce the risk of spontaneous abortion as well as neural tube defects.
| Footnotes |
|---|
Received July 24, 2001. Received in revised form December 28, 2001. Accepted February 7, 2002.
| REFERENCES |
|---|
|
|
|---|
2. Wilcox AJ, Weinberg CR, OConnor JF, Baird DD, Schlatterer JP, Canfield RE, et al. Incidence of early loss of pregnancy. N Engl J Med 1988;319:18994.[Abstract]
3. Hibbard BM. The role of folic acid in pregnancy: With particular reference to anaemia, abruption and abortion. J Obstet Gynaecol Br Commonw 1964;71:52942.[Medline]
4. Nelen WLDM, Blom HJ, Steegers EAP, Den Heijer M, Thomas CMG, Eskes TKAB. Homocysteine and folate levels as risk factors for recurrent pregnancy loss. Obstet Gynecol 2000;95:51924.
5. Hibbard BM. Folates and the fetus. S Afr Med J 1975;49: 12236.[Medline]
6. Scholl TO, Hediger ML, Schall JI, Khoo CS, Fischer RL. Dietary and serum folate: Their influence on the outcome of pregnancy. Am J Clin Nutr 1996;63:5205.
7. Wouters MGAJ, Boers GHJ, Blom HJ, Trijbels FJM, Thomas CMG, Borm GF, et al. Hyperhomocysteinemia: A risk factor in women with unexplained recurrent early pregnancy loss. Fertil Steril 1993;60:8205.[Medline]
8. Goddijn-Wessel TAW, Wouters MGAJ, von der Molen EF, Spuijbroek MDEH, Steegers-Theunissen RPM, Blom HJ, et al. Hyperhomocysteinemia: A risk factor for placental abruption or infarction. Eur J Obstet Gynecol Reprod Biol 1996;66:239.[Medline]
9. Steegers-Theunissen RPM, Boers GHJ, Blom HJ, Trijbels FJM, Eskes TKAB. Hyperhomocysteinaemia and recurrent spontaneous abortion or abruptio placentae. Lancet 1992;339:11223.[Medline]
10. Steegers-Theunissen RPM, Boers GHJ, Trijbels FJM, Finkelstein JD, Blom HJ, Thomas CMG, et al. Maternal hyperhomocysteinemia: A risk factor for neural-tube defects? Metabolism 1994;43:147580.[Medline]
11. Vollset SE, Refsum H, Irgens LM, Emblem BM, Tverdal A, Gjessing HK, et al. Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: The Hordaland Homocysteine Study. Am J Clin Nutr 2000;71:9628.
12. Ray JG, Laskin CA. Folic acid and homocyst(e)ine metabolic defects and the risk of placental abruption, preeclampsia and spontaneous pregnancy loss: A systematic review. Placenta 1999;20:51929.[Medline]
13. Scholl TO, Johnson WG. Folic acid: Influence on the outcome of pregnancy. Am J Clin Nutr 2000;71(Suppl.): 1295S303S.
14. Ronnenberg AG, Goldman MB, Aitken IW, Xu X. Anemia and deficiencies of folate and vitamin B6 are common and vary with season in Chinese women of childbearing age. J Nutr 2000;130:270310.
15. Araki A, Sako Y. Determination of free and total homo-cysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 1987;422:4352.[Medline]
16. Jacques PF, Rosenberg IH, Rogers G, Selhub J, Bowman BA, Gunter EW, et al. Serum homocysteine concentrations in adolescent and adult Americans: Results from the third National Health and Nutrition Examination Survey. Am J Clin Nutr 1999;69:4829.
17. Selhub J, Jacques PF, Wilson PWF, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993; 270:26938.[Abstract]
18. Schwartz SM, Siscovick DS, Malinow MR, Rosendaal FR, Beverly RK, Hess DL, et al. Myocardial infarction in young women in relation to plasma total homocysteine, folate, and a common variant in the methylenetetrahydrofolate reductase gene. Circulation 1997;96:4127.
19. Shin YS, Rasshofer R, Friedrich B, Endres W. Pyridoxal-5'-phosphate determination by a sensitive micromethod in human blood, urine and tissues: Its relation to cystathioninuria in neuroblastoma and biliary atresia. Clin Chim Acta 1983;127:7785.[Medline]
20. Herbert V, Das KC. Folic acid and vitamin B12. In: Shils ME, Olson JA, Shike M, eds. Modern nutrition in health and disease. 8th ed. Philadephia: Lea & Febiger, 1994: 40225.
21. Leklem JE, Reynolds RD. Challenges and direction in the search for clinical applications of vitamin B6. In: Leklem JE, Reynolds RD, eds. Current topics in nutrition and disease. New York: Alan R. Liss, 1988:43754.
22. Koehler KM, Romero LJ, Stauber PM, Pareo-Tubbeh SL, Liang HC, Baumgartner RN, et al. Vitamin supplementation and other variables affecting serum homocysteine and methylmalonic acid concentrations in elderly men and women. J Am Coll Nutr 1996;15:36476.[Abstract]
23. Rosner B. Fundamentals of biostatistics. 4th ed. Boston: Duxbury Press, 1995:3967.
24. National Research Council. Recommended dietary allowances. 10th ed. Food and Nutrition Board. Washington, DC: National Academy Press, 1989.
25. Picciano MF. Is homocysteine a biomarker for identifying women at risk of complications and adverse pregnancy outcomes? Am J Clin Nutr 2000;71:8578.
26. Nelen WLDM, Steegers EAP, Eskes TKAB, Blom HJ. Genetic risk factor for unexplained recurrent early pregnancy loss. Lancet 1997;350:861.[Medline]
27. Grandone E, Margaglione M, Lolaizzo D, Cappucci G, Paladini D, Martinelli P, et al. Factor V Leiden, C>T MTHFR polymorphism and genetic susceptibility to preeclampsia. Thromb Haemost 1997;77:10524.[Medline]
28. Molloy AM, Mills JL, Kirke PN, Ramsbottom D, McPartlin JM, Burke H, et al. Low blood folates in NTD pregnancies are only partly explained by thermolabile 5,10-methylenetetrahydrofolate reductase: Low folate status alone may be the critical factor. Am J Med Genet 1998;78:1559.[Medline]
29. Berry RJ, Li Z, Erickson JD, Li S, Moore CA, Wang H, et al. Prevention of neural-tube defects with folic acid in China. N Engl J Med 1999;341:148590.
30. National Research Council. Recommended dietary allowances. 11th ed. Food and Nutrition Board. Washington, DC: National Academy Press, 1998.
This article has been cited by other articles:
![]() |
S. Mehta, K. P Manji, A. M Young, E. R Brown, C. Chasela, T. E Taha, J. S Read, R. L Goldenberg, and W. W Fawzi Nutritional indicators of adverse pregnancy outcomes and mother-to-child transmission of HIV among HIV-infected women Am. J. Clinical Nutrition, June 1, 2008; 87(6): 1639 - 1649. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Ronnenberg, S. A. Venners, X. Xu, C. Chen, L. Wang, W. Guang, A. Huang, and X. Wang Preconception B-Vitamin and Homocysteine Status, Conception, and Early Pregnancy Loss Am. J. Epidemiol., August 1, 2007; 166(3): 304 - 312. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tamura and M. F. Picciano Folate and human reproduction Am. J. Clinical Nutrition, May 1, 2006; 83(5): 993 - 1016. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Ronnenberg, R. J. Wood, X. Wang, H. Xing, C. Chen, D. Chen, W. Guang, A. Huang, L. Wang, and X. Xu Preconception Hemoglobin and Ferritin Concentrations Are Associated with Pregnancy Outcome in a Prospective Cohort of Chinese Women J. Nutr., October 1, 2004; 134(10): 2586 - 2591. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Villamor, M. L. Dreyfuss, A. Baylin, G. Msamanga, and W. W. Fawzi Weight Loss During Pregnancy Is Associated with Adverse Pregnancy Outcomes among HIV-1 Infected Women J. Nutr., June 1, 2004; 134(6): 1424 - 1431. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Refsum, A. D. Smith, P. M. Ueland, E. Nexo, R. Clarke, J. McPartlin, C. Johnston, F. Engbaek, J. Schneede, C. McPartlin, et al. Facts and Recommendations about Total Homocysteine Determinations: An Expert Opinion Clin. Chem., January 1, 2004; 50(1): 3 - 32. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Ronnenberg, X. Wang, H. Xing, C. Chen, D. Chen, W. Guang, A. Guang, L. Wang, L. Ryan, and X. Xu Low Preconception Body Mass Index Is Associated with Birth Outcome in a Prospective Cohort of Chinese Women J. Nutr., November 1, 2003; 133(11): 3449 - 3455. [Abstract] [Full Text] [PDF] |
||||
![]() |
Vitamin Deficiencies Do Not Cause Spontaneous Abortions Journal Watch Women's Health, August 20, 2002; 2002(820): 6 - 6. [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |